AstraZeneca Statistics

Total Valuation

AstraZeneca has a market cap or net worth of GBP 231.59 billion. The enterprise value is 249.45 billion.

Market Cap	231.59B
Enterprise Value	249.45B

Important Dates

The last earnings date was Tuesday, February 10, 2026.

Earnings Date	Feb 10, 2026
Ex-Dividend Date	Feb 19, 2026

Share Statistics

AstraZeneca has 1.55 billion shares outstanding. The number of shares has decreased by -0.06% in one year.

Current Share Class	1.55B
Shares Outstanding	1.55B
Shares Change (YoY)	-0.06%
Shares Change (QoQ)	+0.13%
Owned by Insiders (%)	0.03%
Owned by Institutions (%)	66.77%
Float	1.54B

Valuation Ratios

The trailing PE ratio is 30.73 and the forward PE ratio is 19.24. AstraZeneca's PEG ratio is 1.59.

PE Ratio	30.73
Forward PE	19.24
PS Ratio	5.31
PB Ratio	6.40
P/TBV Ratio	n/a
P/FCF Ratio	26.49
P/OCF Ratio	21.39
PEG Ratio	1.59

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 17.06, with an EV/FCF ratio of 28.54.

EV / Earnings	32.83
EV / Sales	5.72
EV / EBITDA	17.06
EV / EBIT	23.50
EV / FCF	28.54

Financial Position

The company has a current ratio of 0.94, with a Debt / Equity ratio of 0.61.

Current Ratio	0.94
Quick Ratio	0.65
Debt / Equity	0.61
Debt / EBITDA	1.51
Debt / FCF	2.52
Interest Coverage	10.47

Financial Efficiency

Return on equity (ROE) is 22.84% and return on invested capital (ROIC) is 16.48%.

Return on Equity (ROE)	22.84%
Return on Assets (ROA)	8.19%
Return on Invested Capital (ROIC)	16.48%
Return on Capital Employed (ROCE)	17.12%
Weighted Average Cost of Capital (WACC)	5.18%
Revenue Per Employee	454,142
Profits Per Employee	79,055
Employee Count	94,300
Asset Turnover	0.54
Inventory Turnover	1.81

Taxes

In the past 12 months, AstraZeneca has paid 1.61 billion in taxes.

Income Tax	1.61B
Effective Tax Rate	17.49%

Stock Price Statistics

The stock price has increased by +26.75% in the last 52 weeks. The beta is 0.19, so AstraZeneca's price volatility has been lower than the market average.

Beta (5Y)	0.19
52-Week Price Change	+26.75%
50-Day Moving Average	14,276.52
200-Day Moving Average	12,448.81
Relative Strength Index (RSI)	55.93
Average Volume (20 Days)	2,434,689

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, AstraZeneca had revenue of GBP 43.64 billion and earned 7.60 billion in profits. Earnings per share was 4.86.

Revenue	43.64B
Gross Profit	35.66B
Operating Income	10.62B
Pretax Income	9.21B
Net Income	7.60B
EBITDA	14.33B
EBIT	10.62B
Earnings Per Share (EPS)	4.86

Full Income Statement

Balance Sheet

The company has 4.25 billion in cash and 22.07 billion in debt, giving a net cash position of -17.82 billion or -11.49 per share.

Cash & Cash Equivalents	4.25B
Total Debt	22.07B
Net Cash	-17.82B
Net Cash Per Share	-11.49
Equity (Book Value)	36.20B
Book Value Per Share	23.32
Working Capital	-1.41B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 10.83 billion and capital expenditures -2.09 billion, giving a free cash flow of 8.74 billion.

Operating Cash Flow	10.83B
Capital Expenditures	-2.09B
Free Cash Flow	8.74B
FCF Per Share	5.64

Full Cash Flow Statement

Margins

Gross margin is 81.71%, with operating and profit margins of 24.33% and 17.41%.

Gross Margin	81.71%
Operating Margin	24.33%
Pretax Margin	21.11%
Profit Margin	17.41%
EBITDA Margin	32.82%
EBIT Margin	24.33%
FCF Margin	20.03%

Dividends & Yields

This stock pays an annual dividend of 2.36, which amounts to a dividend yield of 1.58%.

Dividend Per Share	2.36
Dividend Yield	1.58%
Dividend Growth (YoY)	-3.83%
Years of Dividend Growth	1
Payout Ratio	47.39%
Buyback Yield	0.06%
Shareholder Yield	1.61%
Earnings Yield	3.28%
FCF Yield	3.77%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AstraZeneca has an Altman Z-Score of 3.24 and a Piotroski F-Score of 7.

Altman Z-Score	3.24
Piotroski F-Score	7